Alimera Sciences Inc
ALIM
Revenue
27.00M
▲3.99M▲17.34%
3 Months ChangeAssets
150.38M
▼-2.11M▼-1.38%
3 Months ChangeLiabilities
111.59M
▼-243.00k▼-0.2173%
3 Months ChangeFree Cash Flow
-587.00k
▲1.63M▲73.53%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-06-24
Form 8-K
ID: 0001104659-24-074133
2024-06-24
Form 8-K
ID: 0001104659-24-074128
2024-05-14
Form 10-Q
ID: 0001267602-24-000032
2024-05-14
Form 8-K
ID: 0001267602-24-000029
2024-03-07
Form 8-K
ID: 0001267602-24-000016
2024-02-09
Form 8-K
ID: 0001267602-24-000009
2024-01-04
Form 8-K
ID: 0001104659-24-001326
2023-12-12
Form 8-K
ID: 0001267602-23-000129
2023-11-08
Form 8-K
ID: 0001267602-23-000127
2023-11-02
Form 10-Q
ID: 0001267602-23-000125